Pfizer (PFE) Tops Q2 EPS by 14c; raises guidance
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $24.08 -1.19%
EPS Growth %: -12.8%
Financial Fact:
Discontinued operations--net of tax (in dollars per share): 0
Today's EPS Names:
FOMI, FLES, IMMR, More
EPS Growth %: -12.8%
Financial Fact:
Discontinued operations--net of tax (in dollars per share): 0
Today's EPS Names:
FOMI, FLES, IMMR, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q2 EPS of $0.60, $0.14 better than the analyst estimate of $0.46. Revenue for the quarter came in at $13.3 billion versus the consensus estimate of $13.03 billion.
GUIDANCE:
Pfizer sees FY2024 EPS of $2.45-$2.65, versus the consensus of $2.38. Pfizer now sees FY2024 revenue of $59.5-62.5 billion, versus the consensus of $60.7 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Constellation Brands (STZ) Tops Q1 EPS by 18c
- Nike beats quarterly estimates as tariff recovery boosts profit
- Corona-maker Constellation Brands beats estimates, shares jump 2%
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
